Inkef

Anavo Therapeutics is pioneering the systematic drugging of phosphatases, a target area that has long been deemed undruggable. The company focuses on developing first-in-class therapeutic programs, particularly in oncology, leveraging its expertise in phosphatase-driven disease biology and drug discovery. Anavo aims to create a diverse pipeline of therapeutics across various indications by fostering strategic partnerships and collaborations. Through this innovative approach, Anavo seeks to unlock the potential of phosphatase-targeted allosteric modulators, advancing the field of targeted therapies in medicine.

The all-in-one enterprise social intranet, knowledge base, digital workplace, Internal Communications tool and people directory – all working perfectly with Google Suite. Happeo turns G Suite into a unified hub for teamwork. It facilitates managing remote teams and collaboration for enterprise and fast-growing organizations. In 2019, Gartner named Happeo a Cool Vendor. That same year, The Next Web recognized Happeo as one of Europe's fastest-growing scale-ups. Happeo’s own talent is spread across locations, generations, and time zones, helping Happeo’s continued growth of 280% year on year. To learn more visit https://www.happeo.com.

Camel-IDS develops radiopharmaceuticals for cancer patients. Its product, CAM-H2, treats HER2 positive cancers. It also engages in clinical development to treat breast cancer patients; and develops compounds for other cancer indications. The company was incorporated in 2014 and is based in Brussels, Belgium.

ChannelEngine.com B.V. operates a cloud based e-commerce and order management system that connects users to marketplaces and comparison sites. The company develops ChannelEngine that automatically connects new orders from various marketplaces directly to user’s e-commerce system or ERP. Its ChannelEngine also measures clicks and conversions (sales) generated by comparison sites to gain insights into the returns on click costs incurred. The company was founded in 2013 and is based in Leiden, the Netherlands.

Scenic Biotech B.V., founded in 2017 and headquartered in Amsterdam, Netherlands, specializes in developing genomics and immunotherapy technologies aimed at addressing cancer and rare genetic diseases at the genetic level. The company focuses on identifying and harnessing disease suppressing genes, which serve as potential drug targets. By creating innovative therapies that target these genetic suppressors, Scenic Biotech aims to unlock new treatment possibilities for patients suffering from severe diseases.

NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders. Research by the founders working on the neuromuscular junction identified an approach that has not previously been exploited but shows great promise. Importantly, the approach improves neuromuscular transmission in a way that is potentially applicable to a range of clinical indications and orphan human diseases that have profound unmet medical need.

AmbAgon Therapeutics is a developer of cancer molecule therapeutics. The company offers research of a small molecule that augments a tumor-suppressing protein. AmbAgon Therapeutics was founded by Christian Ottmann, Lucas Brunsveld, and Michelle Arkin.

Silverflow B.V. is a cloud-based processing platform based in Amsterdam, Netherlands, specializing in payment gateway solutions for businesses. Founded in 2019, the company enables payment service providers (PSPs), acquirers, and merchants to directly access card networks, facilitating technological advancements in payment processing. Silverflow offers card-acquiring processing as a service, providing real-time insights into transaction fees and access to smart data directly from the networks. This streamlined approach enhances agility, transparency, and security in global payment operations, allowing payment providers to better serve their clients.

ViCentra, they like to keep things simple. ViCentra believe that if products are simple, look beautiful and deliver superb results, they’ll be more enjoyable to use and more likely to help people achieve great things. Creating brilliant products doesn’t end at the manufacturing line though – they also believe in the power of great customer experiences. From our offices in the Netherlands and UK, they’re creating healthcare products with this philosophy firmly in mind. They don’t design for patients – they design for people.

Shapeways, Inc. operates a 3D printing marketplace that allows users to create, buy, and sell custom products across various categories, including art, fashion, home products, gadgets, games, jewelry, DIY items, miniatures, and gifts. Founded in 2008 and headquartered in New York, with additional offices in Eindhoven and Seattle, Shapeways provides an on-demand printing service that ensures each order is uniquely tailored to the customer's specifications. By offering access to advanced 3D printing technology, Shapeways empowers individuals to transform their ideas into tangible products, fostering a community where design and creativity can flourish. The company serves as a platform for users to launch businesses and reach global markets, thereby democratizing the process of product creation.

Cardior Pharmaceuticals GmbH is a biotechnology company based in Hanover, Germany, established in 2016. The company specializes in the development of non-coding RNA-based therapeutics aimed at treating and preventing heart disease, which is the leading cause of death in the western world. Its primary focus is on CDR-132X, an oligonucleotide-based inhibitor designed to target a critical microRNA that regulates harmful changes in the heart resulting from stress or injury. Cardior Pharmaceuticals is positioned as a planned academic spin-off, emphasizing innovative approaches to address significant cardiovascular health challenges.

Castor is an international health-tech company that offers a cloud-based clinical data platform designed to streamline the clinical trial process for researchers around the world. Founded by CEO Derk Arts, MD, Ph.D., the platform is utilized by over 50,000 researchers in 90 countries and has facilitated more than 4,000 studies across diverse therapeutic areas such as diabetes, cardiovascular diseases, rare diseases, infectious diseases, and oncology. Researchers using Castor generate substantial amounts of data from both traditional and remote trials, having reached significant milestones of 180 million data points and 2 million enrolled patients. The company's mission is to enhance the reusability of research data, supporting AI-driven clinical trials and ultimately maximizing the impact of data to improve medical research globally.

Urban Sports Club is a company that promotes a healthier and more active lifestyle through a flexible sports membership model. Founded in 2012 in Berlin by Moritz Kreppel and Benjamin Roth, it offers access to over 50 types of sports, including gym workouts, swimming, yoga, and team sports, across more than 10,000 partner venues in several European countries including Germany, France, Italy, Spain, Portugal, and Belgium. The club caters to both individual users and corporate clients, emphasizing variety and flexibility in fitness options. After initially bootstrapping for two years, the company secured early-stage financing in 2015 and expanded its market presence by acquiring four competitors within Germany, enhancing its service offerings and network. Urban Sports Club aims to reinvent the leisure and company sports market by providing a comprehensive platform for fitness and wellness activities.

Sentinels is an AI-powered transaction monitoring startup. Sentinels provide fintech companies with a cloud-based intelligent transaction monitoring solution dedicated to data-driven compliance for the financial industry and help them crackdown on money laundering and other illegal activity passing.

Onward is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).

Anavo Therapeutics is pioneering the systematic drugging of phosphatases, a target area that has long been deemed undruggable. The company focuses on developing first-in-class therapeutic programs, particularly in oncology, leveraging its expertise in phosphatase-driven disease biology and drug discovery. Anavo aims to create a diverse pipeline of therapeutics across various indications by fostering strategic partnerships and collaborations. Through this innovative approach, Anavo seeks to unlock the potential of phosphatase-targeted allosteric modulators, advancing the field of targeted therapies in medicine.

lengoo powers the future of translation. The AI-first translation tech company has automated the custom-training of neural machine translation systems for enterprise customers, who use the service to have professional translations made in more than 400 language combinations. Over 3,000 business clients, including some of Europe’s biggest enterprises and unicorns, already trust in lengoo’s technology. Headquartered in Berlin, the company was founded in 2014 in Karlsruhe by Philipp Koch-Büttner, Christopher Kränzler, and Alexander Gigga. In 2016, lengoo participated in the Techstars accelerator program in Berlin and in 2018 was awarded with the Deloitte Fast 50 Award as one of the fastest-growing tech companies in Germany with over 600% growth. Christopher Kränzler also holds a seat on the Board of Directors at bitkom, Germany's digital association. Find more info on https://www.lengoo.com lengoo is a certified Language Service Provider according to ISO 17100 and ISO 18587. Find out more! Success stories: https://www.lengoo.com/references Join the team: https://www.lengoo.com/careers

ChannelEngine.com B.V. operates a cloud based e-commerce and order management system that connects users to marketplaces and comparison sites. The company develops ChannelEngine that automatically connects new orders from various marketplaces directly to user’s e-commerce system or ERP. Its ChannelEngine also measures clicks and conversions (sales) generated by comparison sites to gain insights into the returns on click costs incurred. The company was founded in 2013 and is based in Leiden, the Netherlands.

EclecticIQ B.V. is a global provider of threat intelligence, hunting, and response technology, supporting government organizations and commercial enterprises in enhancing their cybersecurity posture. Founded in 2014 and headquartered in Amsterdam, with additional offices in Herndon, Virginia; London, United Kingdom; and Chi?inau, Moldova, the company offers a range of products and services. These include the EclecticIQ Platform, a comprehensive threat intelligence platform; the EclecticIQ Fusion Center, which delivers multi-source threat intelligence bundles; and the EclecticIQ Academy for cyber threat intelligence training. The company also provides consulting services, team collaboration tools, and various integrations to optimize incident response and security controls. With a focus on building defenses against emerging threats, EclecticIQ has expanded its capabilities through acquisitions, such as Polylogyx's endpoint technology, to further enhance its offerings for clients facing sophisticated cyber threats.

Silverflow B.V. is a cloud-based processing platform based in Amsterdam, Netherlands, specializing in payment gateway solutions for businesses. Founded in 2019, the company enables payment service providers (PSPs), acquirers, and merchants to directly access card networks, facilitating technological advancements in payment processing. Silverflow offers card-acquiring processing as a service, providing real-time insights into transaction fees and access to smart data directly from the networks. This streamlined approach enhances agility, transparency, and security in global payment operations, allowing payment providers to better serve their clients.

EclecticIQ B.V. is a global provider of threat intelligence, hunting, and response technology, supporting government organizations and commercial enterprises in enhancing their cybersecurity posture. Founded in 2014 and headquartered in Amsterdam, with additional offices in Herndon, Virginia; London, United Kingdom; and Chi?inau, Moldova, the company offers a range of products and services. These include the EclecticIQ Platform, a comprehensive threat intelligence platform; the EclecticIQ Fusion Center, which delivers multi-source threat intelligence bundles; and the EclecticIQ Academy for cyber threat intelligence training. The company also provides consulting services, team collaboration tools, and various integrations to optimize incident response and security controls. With a focus on building defenses against emerging threats, EclecticIQ has expanded its capabilities through acquisitions, such as Polylogyx's endpoint technology, to further enhance its offerings for clients facing sophisticated cyber threats.

Salvia BioElectronics B.V., founded in 2017 and based in Eindhoven, the Netherlands, specializes in developing bioelectronic therapies for individuals with chronic neurological diseases. The company operates in the burgeoning field of bioelectronics, merging principles of biology and electronics to create innovative therapeutic solutions. The name "Salvia," derived from the Latin word for "to stay healthy," reflects the company's commitment to enhancing health and well-being. Salvia aims to deliver accessible bioelectronic treatments that address severe neurological disorders. The team comprises experienced professionals from diverse backgrounds in the medical device industry, including notable companies such as Medtronic and Philips, ensuring a strong foundation for the development of their cutting-edge technologies.

Castor is an international health-tech company that offers a cloud-based clinical data platform designed to streamline the clinical trial process for researchers around the world. Founded by CEO Derk Arts, MD, Ph.D., the platform is utilized by over 50,000 researchers in 90 countries and has facilitated more than 4,000 studies across diverse therapeutic areas such as diabetes, cardiovascular diseases, rare diseases, infectious diseases, and oncology. Researchers using Castor generate substantial amounts of data from both traditional and remote trials, having reached significant milestones of 180 million data points and 2 million enrolled patients. The company's mission is to enhance the reusability of research data, supporting AI-driven clinical trials and ultimately maximizing the impact of data to improve medical research globally.

iOnctura SA is a biopharmaceutical company based in Geneva, Switzerland, founded in 2017. The company focuses on developing innovative therapeutics aimed at modulating immunosuppression within the tumor microenvironment, which is a significant barrier to effective cancer treatment. Its product pipeline includes selective Pi3K inhibitors, Anti-Lag 3 antibodies, ATX inhibitors, Anti-CXCL12 antibodies, and Anti-CD73 antibodies. iOnctura aims to enhance the efficacy of existing immune checkpoint therapies by creating novel drugs that, when used in combination with these therapies, can optimize clinical outcomes for cancer patients. The company has formed partnerships with Merck and Cancer Research Technology, leveraging their resources to advance its preclinical molecules and establish promising combination therapies within cancer immunology. Supported by a distinguished scientific advisory board, iOnctura is well-positioned to innovate in the rapidly evolving field of cancer treatment.

ViCentra, they like to keep things simple. ViCentra believe that if products are simple, look beautiful and deliver superb results, they’ll be more enjoyable to use and more likely to help people achieve great things. Creating brilliant products doesn’t end at the manufacturing line though – they also believe in the power of great customer experiences. From our offices in the Netherlands and UK, they’re creating healthcare products with this philosophy firmly in mind. They don’t design for patients – they design for people.

VarmX B.V., a biotechnology company, develops therapies in the field of hemostasis and thrombosis. It develops PseudoXa, a therapeutic protein that is used to stop bleeding of patients who use blood thinners. The company was founded in 2016 and is based in Leiden, the Netherlands.

The all-in-one enterprise social intranet, knowledge base, digital workplace, Internal Communications tool and people directory – all working perfectly with Google Suite. Happeo turns G Suite into a unified hub for teamwork. It facilitates managing remote teams and collaboration for enterprise and fast-growing organizations. In 2019, Gartner named Happeo a Cool Vendor. That same year, The Next Web recognized Happeo as one of Europe's fastest-growing scale-ups. Happeo’s own talent is spread across locations, generations, and time zones, helping Happeo’s continued growth of 280% year on year. To learn more visit https://www.happeo.com.

Quantum Motion Technologies Limited is focused on developing a technology platform that utilizes an array of qubits to create innovative quantum computing architectures. Established in 2017 and based in Leeds, United Kingdom, the company aims to build a universal quantum computer using silicon and CMOS-compatible processes. Its quantum computing technology is designed to address complex challenges across various fields, including chemistry, medicine, and artificial intelligence.

QurAlis Corporation is a biotechnology company focused on discovering and developing precision therapeutics for amyotrophic lateral sclerosis (ALS) and other neurological diseases. Established in 2016 and based in Cambridge, Massachusetts, QurAlis aims to address the genetic underpinnings of ALS, leveraging its proprietary platforms and biomarkers to create targeted treatments. The company's pipeline includes innovative therapies designed to restore dysfunctional cellular processes, treat overactive neurons, and eliminate toxic proteins associated with the disease. By concentrating on genetically validated targets, QurAlis seeks to advance antisense oligonucleotides and small molecule programs that can effectively manage various subtypes of ALS, ultimately working to halt disease progression and improve patient outcomes. QurAlis operates as a subsidiary of Q-State Biosciences, Inc.

Remote Technology, Inc. provides a comprehensive human resource technology platform that specializes in payroll, benefits, compliance, and tax services for businesses with distributed employees and contractors. Founded in 2017 and based in San Francisco, California, the company facilitates onboarding, automatic payments, and centralized document management, while also handling statutory payments, social and pension contributions, and income tax retention. By connecting candidates with remote job opportunities, Remote allows companies to focus on their workforce without the complexities of managing global payroll and regulatory compliance.

Remote Technology, Inc. provides a comprehensive human resource technology platform that specializes in payroll, benefits, compliance, and tax services for businesses with distributed employees and contractors. Founded in 2017 and based in San Francisco, California, the company facilitates onboarding, automatic payments, and centralized document management, while also handling statutory payments, social and pension contributions, and income tax retention. By connecting candidates with remote job opportunities, Remote allows companies to focus on their workforce without the complexities of managing global payroll and regulatory compliance.

iOnctura SA is a biopharmaceutical company based in Geneva, Switzerland, founded in 2017. The company focuses on developing innovative therapeutics aimed at modulating immunosuppression within the tumor microenvironment, which is a significant barrier to effective cancer treatment. Its product pipeline includes selective Pi3K inhibitors, Anti-Lag 3 antibodies, ATX inhibitors, Anti-CXCL12 antibodies, and Anti-CD73 antibodies. iOnctura aims to enhance the efficacy of existing immune checkpoint therapies by creating novel drugs that, when used in combination with these therapies, can optimize clinical outcomes for cancer patients. The company has formed partnerships with Merck and Cancer Research Technology, leveraging their resources to advance its preclinical molecules and establish promising combination therapies within cancer immunology. Supported by a distinguished scientific advisory board, iOnctura is well-positioned to innovate in the rapidly evolving field of cancer treatment.

Draupnir Bio is focused on developing innovative cholesterol-lowering medications aimed at preventing blood clots in the heart with greater efficacy than existing treatments. The company utilizes a platform that explores the glycome to create novel therapeutics, employing advanced techniques in array technology, protein chemistry, and carbohydrate chemistry. This platform enables the synthesis, screening, and selection of potent heparan sulfate glycomimetic drug candidates, targeting cardiovascular, inflammatory, and infectious diseases. Additionally, Draupnir Bio's technology includes the development of protein degraders that can target extracellular disease proteins, potentially addressing a wide range of unmet therapeutic needs across various medical conditions. This approach promises more convenient and accessible treatment options compared to traditional injectable therapies.

Cashforce BV operates a smart cash flow management and forecasting platform designed to help organizations optimize their financial operations. Founded in 2013 and headquartered in Antwerp, Belgium, with additional offices in New York, Amsterdam, Copenhagen, and London, the company serves sectors such as wholesale and distribution, transportation, logistics, and manufacturing. The platform allows users to forecast cash flows across multiple companies, bank accounts, and currencies, enabling them to identify potential cash shortages or surpluses in advance. Cashforce's unique offerings include seamless integration with various ERP and banking systems, detailed transaction-level visibility, and an AI-based simulation engine that supports multiple cash flow scenarios and impact analyses. The company has a strategic alliance with Treasury Intelligence Solutions GmbH and provides cash visibility to multinational corporations in over 120 countries.

EclecticIQ B.V. is a global provider of threat intelligence, hunting, and response technology, supporting government organizations and commercial enterprises in enhancing their cybersecurity posture. Founded in 2014 and headquartered in Amsterdam, with additional offices in Herndon, Virginia; London, United Kingdom; and Chi?inau, Moldova, the company offers a range of products and services. These include the EclecticIQ Platform, a comprehensive threat intelligence platform; the EclecticIQ Fusion Center, which delivers multi-source threat intelligence bundles; and the EclecticIQ Academy for cyber threat intelligence training. The company also provides consulting services, team collaboration tools, and various integrations to optimize incident response and security controls. With a focus on building defenses against emerging threats, EclecticIQ has expanded its capabilities through acquisitions, such as Polylogyx's endpoint technology, to further enhance its offerings for clients facing sophisticated cyber threats.

Urban Sports Club is a company that promotes a healthier and more active lifestyle through a flexible sports membership model. Founded in 2012 in Berlin by Moritz Kreppel and Benjamin Roth, it offers access to over 50 types of sports, including gym workouts, swimming, yoga, and team sports, across more than 10,000 partner venues in several European countries including Germany, France, Italy, Spain, Portugal, and Belgium. The club caters to both individual users and corporate clients, emphasizing variety and flexibility in fitness options. After initially bootstrapping for two years, the company secured early-stage financing in 2015 and expanded its market presence by acquiring four competitors within Germany, enhancing its service offerings and network. Urban Sports Club aims to reinvent the leisure and company sports market by providing a comprehensive platform for fitness and wellness activities.

Comet Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2018. The company focuses on developing novel small-molecule therapies aimed at treating orphan neurological disorders through its Coenzyme metabolism platform. By targeting dysregulated Coenzyme A metabolism, Comet Therapeutics seeks to address significant unmet medical needs in the field of neurology, providing potential treatments for conditions that currently lack effective options.

Withlocals B.V. owns and operates a Website that connects travelers with locals through food and experiences. Its Website operates as a marketplace for local tours, activities, home restaurants, and private guides. The company's Website also enables travelers to enjoy local experiences, buy directly from local hosts, and meet new friends in Thailand, Vietnam, Nepal, Indonesia, Singapore, and Sri Lanka. Withlocals B.V. was founded in 2013 and is based in Eindhoven, the Netherlands.

Calypso Biotech is an innovative biopharmaceutical company based in Geneva, Switzerland and founded in 2013 as a spin-off from Merck Serono, a global leader in auto-immune diseases and biologics. Calypso Biotech was initially financed through a 2.5 million euro seed-fund managed by MS Ventures.A highly experienced management team with strong expertise in drug development and an extensive scientific and industry network manages Calypso Biotech. They operate as a nimble, semi-virtual organization in order to create substantial added value for their investors from a portfolio of unique proprietary antibody candidates.

Aidence B.V. develops and delivers a software platform for radiologists that automatically detects, classifies, and tracks the disorder on multiple imaging modalities. The company provides artificial intelligence solution that enables computer to read medical images and automatically provide structured reports. Aidence B.V. was founded in 2015 and is based in Amsterdam, the Netherlands.

GeoPhy provides database and analytics tools for the property and financial sector. It offers data warehouse that allows users with access to data at the building, portfolio, area, city, and country level, and also enables users to check, monitor, structure, analyze, and export the data; and solutions to optimize investment portfolio by tracking investments. Sander Mulders and Teun van den Dries founded OfficeRank on June 1, 2014 that became GeoPhy in March 2015. It has its headquarters in Delft in the Netherlands.

Polarsteps is a travel app designed to help users plan, track, and share their journeys effectively. The app automatically records travel routes as users move, ensuring that no details of their trips are missed. Once the user is connected to the internet, the app uploads the travel information, including key locations and photos, to a personal Polarsteps page. This page displays the user’s route on a colorful world map, allowing for easy sharing with friends and family. By combining functionality with an appealing interface, Polarsteps aims to enhance the travel experience and help users turn their travel moments into lasting memories.

GitLab is a web-based open source Git repository manager with wiki and issue tracking features and built-in CI/CD. It is an open-source code collaboration platform that enables developers to create, review, and deploy codebases. The company's open-source, code-collaboration platform offers git repository management, code reviews, issue tracking, wikis, and more, along with continuous integration and deployment tools, enabling users to create, review and deploy codes. It was founded in 2014 and is headquartered in San Francisco, California.

Castor is an international health-tech company that offers a cloud-based clinical data platform designed to streamline the clinical trial process for researchers around the world. Founded by CEO Derk Arts, MD, Ph.D., the platform is utilized by over 50,000 researchers in 90 countries and has facilitated more than 4,000 studies across diverse therapeutic areas such as diabetes, cardiovascular diseases, rare diseases, infectious diseases, and oncology. Researchers using Castor generate substantial amounts of data from both traditional and remote trials, having reached significant milestones of 180 million data points and 2 million enrolled patients. The company's mission is to enhance the reusability of research data, supporting AI-driven clinical trials and ultimately maximizing the impact of data to improve medical research globally.

Rainier Therapeutics, Inc., a biotechnology company, develops a targeted biologic for the potential treatment of early stage and metastatic bladder cancer. It offers Vofatamab (B-701), a human monoclonal antibody that targets and specifically blocks the activity of FGFR3 (fibroblast growth factor receptor 3) that is used for the treatment for metastatic bladder cancer. Rainier Therapeutics, Inc. was formerly known as BioClin Therapeutics, Inc. and changed its name to Rainier Therapeutics, Inc. in November 2018. The company was founded in 2010 and is based in San Leandro, California.

OneFit is active in the Netherlands, Germany, and Spain

Shapeways, Inc. operates a 3D printing marketplace that allows users to create, buy, and sell custom products across various categories, including art, fashion, home products, gadgets, games, jewelry, DIY items, miniatures, and gifts. Founded in 2008 and headquartered in New York, with additional offices in Eindhoven and Seattle, Shapeways provides an on-demand printing service that ensures each order is uniquely tailored to the customer's specifications. By offering access to advanced 3D printing technology, Shapeways empowers individuals to transform their ideas into tangible products, fostering a community where design and creativity can flourish. The company serves as a platform for users to launch businesses and reach global markets, thereby democratizing the process of product creation.

NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders. Research by the founders working on the neuromuscular junction identified an approach that has not previously been exploited but shows great promise. Importantly, the approach improves neuromuscular transmission in a way that is potentially applicable to a range of clinical indications and orphan human diseases that have profound unmet medical need.

Health Value Creation is developing two surgical devices, a diagnostic tool and a trocar closure device. The first device helps prevent anastomotic leakages after bowel surgery by predicting the quality of the anastomosis during surgery, thereby reducing post-operative complications and lowering healthcare costs. The second device is a trocar closure device for faster, safer and more secure suturing after laparoscopic surgery, resulting in a reduction of the chances of wound herniation.

Withlocals B.V. owns and operates a Website that connects travelers with locals through food and experiences. Its Website operates as a marketplace for local tours, activities, home restaurants, and private guides. The company's Website also enables travelers to enjoy local experiences, buy directly from local hosts, and meet new friends in Thailand, Vietnam, Nepal, Indonesia, Singapore, and Sri Lanka. Withlocals B.V. was founded in 2013 and is based in Eindhoven, the Netherlands.

GitLab is a web-based open source Git repository manager with wiki and issue tracking features and built-in CI/CD. It is an open-source code collaboration platform that enables developers to create, review, and deploy codebases. The company's open-source, code-collaboration platform offers git repository management, code reviews, issue tracking, wikis, and more, along with continuous integration and deployment tools, enabling users to create, review and deploy codes. It was founded in 2014 and is headquartered in San Francisco, California.

Scenic Biotech B.V., founded in 2017 and headquartered in Amsterdam, Netherlands, specializes in developing genomics and immunotherapy technologies aimed at addressing cancer and rare genetic diseases at the genetic level. The company focuses on identifying and harnessing disease suppressing genes, which serve as potential drug targets. By creating innovative therapies that target these genetic suppressors, Scenic Biotech aims to unlock new treatment possibilities for patients suffering from severe diseases.

Blendle operates as a digital platform that allows readers to purchase individual articles from various Dutch newspapers and some Belgian publishers, as well as select magazines like the Economist. Articles are priced between €0.10 and €0.30, and the platform is designed to resemble an iTunes model for news content. Users can explore major front pages and receive recommendations for specific articles, presented in a social media-style format. New users are initially credited with €2.50, and approximately 20% of them exceed this amount in spending. Buyers have a limited period to cancel their purchases for a refund, after which Blendle retains a 30% commission on sales.

Bloomon B.V. is an online retailer based in Amsterdam, Netherlands, specializing in the delivery of quality flowers across Europe. Founded in 2014, the company provides a platform that connects consumers directly with flower growers. Bloomon operates on a subscription model, allowing customers to easily arrange their orders online, and offering the flexibility to pause, change, or cancel deliveries without commitment. This model enhances the customer experience by allowing users to customize their flower arrangements and packaging. Bloomon prioritizes client satisfaction and product quality, focusing on providing unique floral experiences rather than competing with other businesses in the market.

GitLab is a web-based open source Git repository manager with wiki and issue tracking features and built-in CI/CD. It is an open-source code collaboration platform that enables developers to create, review, and deploy codebases. The company's open-source, code-collaboration platform offers git repository management, code reviews, issue tracking, wikis, and more, along with continuous integration and deployment tools, enabling users to create, review and deploy codes. It was founded in 2014 and is headquartered in San Francisco, California.

NightBalance B.V. develops and markets an obstructive sleep apnea (OSA) device for the treatment of positional obstructive sleep apnea to customers in Europe. It develops Sleep Position Trainer (SPT), which measures the sleep behavior of the patient continuously; gives a gentle vibration once the patient turns into the supine position; and reminds the patient to change their sleeping position without disrupting their natural sleeping architecture. The company was founded in 2009 and is based in The Hague, the Netherlands. As of May 8, 2018, NightBalance B.V. operates as a subsidiary of Koninklijke Philips N.V.

GeoPhy provides database and analytics tools for the property and financial sector. It offers data warehouse that allows users with access to data at the building, portfolio, area, city, and country level, and also enables users to check, monitor, structure, analyze, and export the data; and solutions to optimize investment portfolio by tracking investments. Sander Mulders and Teun van den Dries founded OfficeRank on June 1, 2014 that became GeoPhy in March 2015. It has its headquarters in Delft in the Netherlands.

EclecticIQ B.V. is a global provider of threat intelligence, hunting, and response technology, supporting government organizations and commercial enterprises in enhancing their cybersecurity posture. Founded in 2014 and headquartered in Amsterdam, with additional offices in Herndon, Virginia; London, United Kingdom; and Chi?inau, Moldova, the company offers a range of products and services. These include the EclecticIQ Platform, a comprehensive threat intelligence platform; the EclecticIQ Fusion Center, which delivers multi-source threat intelligence bundles; and the EclecticIQ Academy for cyber threat intelligence training. The company also provides consulting services, team collaboration tools, and various integrations to optimize incident response and security controls. With a focus on building defenses against emerging threats, EclecticIQ has expanded its capabilities through acquisitions, such as Polylogyx's endpoint technology, to further enhance its offerings for clients facing sophisticated cyber threats.

Onward is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).

Crowdynews helps content reach its full potential by creating more credible, more encompassing, and more valuable connections between content creators and content consumers. Our AI-driven user-generated content curation engine provides a one-stop shop for automating the inclusion of relevant, real-time, and safe content from Twitter, Facebook, Instagram, YouTube, Vimeo, and more alongside content developed by news media and brands. Using artificial intelligence & natural language processing, we enable our customers to tell “the whole story” by augmenting their own content with photos, videos, eyewitness reports, and opinions shared through social media & on the web, driving engagement, improving conversion, and increasing revenue.

Wercker B.V. is a company that operates a cloud-based platform designed to assist developers in the automation of application and microservices development. Founded in 2012 and headquartered in Amsterdam, with additional offices in London and San Francisco, the platform facilitates code testing and interaction with various services, while incorporating social features that allow team members to track builds and deployments. It enables collaboration by allowing users to invite others to their projects and integrates seamlessly with popular developer tools. The platform supports a build/test/deploy workflow without requiring users to leave their local development environment, streamlining the process of building, deploying, and monitoring applications.

ViCentra, they like to keep things simple. ViCentra believe that if products are simple, look beautiful and deliver superb results, they’ll be more enjoyable to use and more likely to help people achieve great things. Creating brilliant products doesn’t end at the manufacturing line though – they also believe in the power of great customer experiences. From our offices in the Netherlands and UK, they’re creating healthcare products with this philosophy firmly in mind. They don’t design for patients – they design for people.

InteRNA Technologies B.V. is a biotechnology company based in Nijmegen, the Netherlands, with a research and development center in Utrecht. Founded in 2006, the company focuses on developing microRNA (miRNA)-based therapeutics aimed at treating cancer. These drugs target previously undruggable pathways, enhancing the effectiveness of existing therapies and addressing drug resistance. InteRNA employs advanced techniques such as massively parallel sequencing and proprietary bioinformatics to analyze and validate miRNA sequences. Recently, the company secured additional equity financing to further advance its lead program for melanoma treatment, reflecting its commitment to innovation in oncology.

Audion Therapeutics BV is a biopharmaceutical company based in Amsterdam, the Netherlands, that specializes in the discovery, development, and commercialization of therapeutic drugs and delivery technologies for ear-related diseases, particularly hearing loss. Founded in 2008, the company is focused on a small molecule drug discovery program aimed at regenerating inner hair cells, which are crucial for hearing. Audion Therapeutics holds a comprehensive intellectual property portfolio that includes innovative molecules, advanced delivery systems, and drug discovery tools specifically designed for hearing and hearing loss research.

Bloomon B.V. is an online retailer based in Amsterdam, Netherlands, specializing in the delivery of quality flowers across Europe. Founded in 2014, the company provides a platform that connects consumers directly with flower growers. Bloomon operates on a subscription model, allowing customers to easily arrange their orders online, and offering the flexibility to pause, change, or cancel deliveries without commitment. This model enhances the customer experience by allowing users to customize their flower arrangements and packaging. Bloomon prioritizes client satisfaction and product quality, focusing on providing unique floral experiences rather than competing with other businesses in the market.

Shapeways, Inc. operates a 3D printing marketplace that allows users to create, buy, and sell custom products across various categories, including art, fashion, home products, gadgets, games, jewelry, DIY items, miniatures, and gifts. Founded in 2008 and headquartered in New York, with additional offices in Eindhoven and Seattle, Shapeways provides an on-demand printing service that ensures each order is uniquely tailored to the customer's specifications. By offering access to advanced 3D printing technology, Shapeways empowers individuals to transform their ideas into tangible products, fostering a community where design and creativity can flourish. The company serves as a platform for users to launch businesses and reach global markets, thereby democratizing the process of product creation.

Crowdynews helps content reach its full potential by creating more credible, more encompassing, and more valuable connections between content creators and content consumers. Our AI-driven user-generated content curation engine provides a one-stop shop for automating the inclusion of relevant, real-time, and safe content from Twitter, Facebook, Instagram, YouTube, Vimeo, and more alongside content developed by news media and brands. Using artificial intelligence & natural language processing, we enable our customers to tell “the whole story” by augmenting their own content with photos, videos, eyewitness reports, and opinions shared through social media & on the web, driving engagement, improving conversion, and increasing revenue.

Aito BV, founded in 2005 and based in Zaanstad, the Netherlands, specializes in developing and manufacturing advanced touch solutions for various applications. The company creates interactive user interfaces that incorporate buttons, touch pads, and screens, utilizing materials like stainless steel, aluminum, wood, and polycarbonate. Aito's product range includes touch demos, complete switching units, touch water taps, and control units designed for consumer electronics such as smartphones and car infotainment systems. The company is recognized for its patented touch and haptic feedback technology, which enhances user experience. With engineering and research offices in the Netherlands and Finland, and licensed manufacturing facilities in Singapore and China, Aito serves a global clientele through its sales and application team located in Amsterdam. Aito operates as a subsidiary of d-Switch BV.

Aito BV, founded in 2005 and based in Zaanstad, the Netherlands, specializes in developing and manufacturing advanced touch solutions for various applications. The company creates interactive user interfaces that incorporate buttons, touch pads, and screens, utilizing materials like stainless steel, aluminum, wood, and polycarbonate. Aito's product range includes touch demos, complete switching units, touch water taps, and control units designed for consumer electronics such as smartphones and car infotainment systems. The company is recognized for its patented touch and haptic feedback technology, which enhances user experience. With engineering and research offices in the Netherlands and Finland, and licensed manufacturing facilities in Singapore and China, Aito serves a global clientele through its sales and application team located in Amsterdam. Aito operates as a subsidiary of d-Switch BV.

Equity finance for SME + SME exchange

Shapeways, Inc. operates a 3D printing marketplace that allows users to create, buy, and sell custom products across various categories, including art, fashion, home products, gadgets, games, jewelry, DIY items, miniatures, and gifts. Founded in 2008 and headquartered in New York, with additional offices in Eindhoven and Seattle, Shapeways provides an on-demand printing service that ensures each order is uniquely tailored to the customer's specifications. By offering access to advanced 3D printing technology, Shapeways empowers individuals to transform their ideas into tangible products, fostering a community where design and creativity can flourish. The company serves as a platform for users to launch businesses and reach global markets, thereby democratizing the process of product creation.

ViCentra, they like to keep things simple. ViCentra believe that if products are simple, look beautiful and deliver superb results, they’ll be more enjoyable to use and more likely to help people achieve great things. Creating brilliant products doesn’t end at the manufacturing line though – they also believe in the power of great customer experiences. From our offices in the Netherlands and UK, they’re creating healthcare products with this philosophy firmly in mind. They don’t design for patients – they design for people.

Sapiens Steering Brain Stimulation GmbH is an emerging medical device company whose mission is to deliver superior solutions for deep brain stimulation (DBS) therapy. Sapiens' ambition is to provide a unique, high-resolution, and MRI- compatible DBS system that will improve patient comfort and therapeutic outcome, initially for patients with Parkinson's disease. Sapiens, with offices in Eindhoven, the Netherlands and Munich, Germany, is founded in 2011 as a spin-out of Royal Philips Electronics. Its steering brain stimulation (SBS) system and image-guided programming are based upon patented technologies.

Lanthio Pharma is a privately held drug discovery company that applies its proprietary lanthionine-peptide drug discovery technology LanthioPepTM for the generation of novel peptide therapeutics with increased resistance to peptidase degradation, high receptor specificity and increased intrinsic activity. Lanthio Pharma has generated stable, peptidase-resistant lanthionine peptides with highly specific agonistic activity for a number of GPCR targets, which is a focus area of the company.

Equity finance for SME + SME exchange

Robin Radar Systems B.V. develops and delivers bird detection systems to view bird movements. Its systems include 2D Mobile system, a radar that identifies the presence and number of birds in time that includes their location, direction, speed, and route–up to 20 kilometers; 3D Fixed system that identifies the presence and number of birds in time, including their location, height, direction, speed, and route–up to 10 kilometers; 3D Flex system that consists of a horizontal S-band radar that is combined with a flexible frequency modulated continuous wave radar; and Military XL, a surveillance radar system that helps air force to prevent bird strikes. The company also provides testing, training, documentation, maintenance, and support services. Robin Radar Systems B.V. is based in The Hague, the Netherlands.

ProFibrix B.V., a biotech company, creates, develops, and markets products for the hemostasis and regenerative medicine markets. Its products include Fibrocaps, a dry powder topical hemostat and tissue sealant based on a mixture of fibrinogen and thrombin, which stops acute and severe bleeding during surgery or in connection with trauma injury. The company also provides a sterilized single-use delivery device to deliver Fibrocaps to the target tissue area without the need to manipulate the wound in a surgical environment. It offers its products based on human fibrinogen, a natural blood protein for haemostasis, blood clotting, and tissue repair and healing. ProFibrix B.V. was founded in 2004